Log in

NASDAQ:EOLSEvolus News Headlines

$3.86
+0.08 (+2.12 %)
(As of 04/6/2020 08:45 AM ET)
Add
Compare
Today's Range
$3.72
Now: $3.86
$4.00
50-Day Range
$3.53
MA: $6.76
$10.47
52-Week Range
$3.12
Now: $3.86
$29.40
Volume368,355 shs
Average Volume661,873 shs
Market Capitalization$130.20 million
P/E RatioN/A
Dividend YieldN/A
Beta4.13

Headlines

Evolus (NASDAQ EOLS) News Headlines

Source:
DateHeadline
Time To Worry? Analysts Are Downgrading Their Evolus, Inc. (NASDAQ:EOLS) Outlook - Yahoo FinanceTime To Worry? Analysts Are Downgrading Their Evolus, Inc. (NASDAQ:EOLS) Outlook - Yahoo Finance
finance.yahoo.com - April 5 at 10:18 AM
Time To Worry? Analysts Are Downgrading Their Evolus, Inc. (NASDAQ:EOLS) OutlookTime To Worry? Analysts Are Downgrading Their Evolus, Inc. (NASDAQ:EOLS) Outlook
finance.yahoo.com - April 5 at 10:18 AM
SVB Leerink Cuts Evolus (NASDAQ:EOLS) Price Target to $15.00SVB Leerink Cuts Evolus (NASDAQ:EOLS) Price Target to $15.00
www.americanbankingnews.com - April 3 at 12:57 PM
$19.64 Million in Sales Expected for Evolus Inc (NASDAQ:EOLS) This Quarter$19.64 Million in Sales Expected for Evolus Inc (NASDAQ:EOLS) This Quarter
www.americanbankingnews.com - March 28 at 5:11 AM
Evolus Inc (NASDAQ:EOLS) Short Interest Down 17.1% in MarchEvolus Inc (NASDAQ:EOLS) Short Interest Down 17.1% in March
www.americanbankingnews.com - March 27 at 12:18 PM
HC Wainwright Lowers Evolus (NASDAQ:EOLS) Price Target to $16.00HC Wainwright Lowers Evolus (NASDAQ:EOLS) Price Target to $16.00
www.americanbankingnews.com - March 27 at 7:59 AM
Evolus Inc (NASDAQ:EOLS) Expected to Announce Earnings of -$0.57 Per ShareEvolus Inc (NASDAQ:EOLS) Expected to Announce Earnings of -$0.57 Per Share
www.americanbankingnews.com - March 26 at 5:22 AM
EOLS Mar 2020 16.000 callEOLS Mar 2020 16.000 call
finance.yahoo.com - March 21 at 7:00 AM
Evolus Inc (NASDAQ:EOLS) Given Consensus Rating of "Buy" by BrokeragesEvolus Inc (NASDAQ:EOLS) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - March 12 at 7:54 PM
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19 - BenzingaThe Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19 - Benzinga
www.benzinga.com - March 5 at 7:05 PM
Evolus Provides Update on International Trade Commission (ITC) Case - Yahoo FinanceEvolus Provides Update on International Trade Commission (ITC) Case - Yahoo Finance
finance.yahoo.com - March 5 at 9:04 AM
BRIEF-Evolus Provides Update On International Trade Commission Case - ReutersBRIEF-Evolus Provides Update On International Trade Commission Case - Reuters
www.reuters.com - March 4 at 3:01 PM
Evolus down 16.5% on "speculative" comments from Jeuveau competitor - Seeking AlphaEvolus down 16.5% on "speculative" comments from Jeuveau competitor - Seeking Alpha
seekingalpha.com - March 4 at 3:01 PM
Evolus to Participate in Barclays 2020 Global Healthcare Conference - GlobeNewswireEvolus to Participate in Barclays 2020 Global Healthcare Conference - GlobeNewswire
www.globenewswire.com - March 3 at 12:47 PM
Evolus to Participate in Barclays 2020 Global Healthcare ConferenceEvolus to Participate in Barclays 2020 Global Healthcare Conference
finance.yahoo.com - March 3 at 12:47 PM
Edited Transcript of EOLS.OQ earnings conference call or presentation 25-Feb-20 1:00pm GMT - Yahoo FinanceEdited Transcript of EOLS.OQ earnings conference call or presentation 25-Feb-20 1:00pm GMT - Yahoo Finance
finance.yahoo.com - March 2 at 7:46 PM
Implied Volatility Surging for Evolus (EOLS) Stock Options - Yahoo FinanceImplied Volatility Surging for Evolus (EOLS) Stock Options - Yahoo Finance
finance.yahoo.com - February 28 at 10:35 PM
Implied Volatility Surging for Evolus (EOLS) Stock Options - NasdaqImplied Volatility Surging for Evolus (EOLS) Stock Options - Nasdaq
www.nasdaq.com - February 28 at 12:33 PM
Evolus EPS beats by $0.46, beats on revenueEvolus EPS beats by $0.46, beats on revenue
seekingalpha.com - February 27 at 2:48 PM
Evolus (EOLS) PT Lowered to $31 at HC Wainwright - StreetInsider.comEvolus (EOLS) PT Lowered to $31 at HC Wainwright - StreetInsider.com
www.streetinsider.com - February 26 at 1:42 PM
Evolus, Inc. (EOLS) CEO David Moatazedi on Q4 2019 Results - Earnings Call Transcript - Seeking AlphaEvolus, Inc. (EOLS) CEO David Moatazedi on Q4 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 25 at 11:35 PM
Evolus, Inc. (EOLS) Q4 2019 Earnings Call Transcript - Motley FoolEvolus, Inc. (EOLS) Q4 2019 Earnings Call Transcript - Motley Fool
www.fool.com - February 25 at 11:35 PM
Evolus +5% premarket on Q4 beat - Seeking AlphaEvolus +5% premarket on Q4 beat - Seeking Alpha
seekingalpha.com - February 25 at 1:34 PM
Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update - Yahoo FinanceEvolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - February 25 at 1:34 PM
Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update - GlobeNewswireEvolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update - GlobeNewswire
www.globenewswire.com - February 25 at 8:34 AM
Evolus, Inc. to Host Earnings CallEvolus, Inc. to Host Earnings Call
finance.yahoo.com - February 25 at 8:34 AM
Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business UpdateEvolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update
finance.yahoo.com - February 25 at 8:34 AM
Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference - StreetInsider.comEvolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference - StreetInsider.com
www.streetinsider.com - February 14 at 12:30 PM
Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference - Yahoo FinanceEvolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - February 13 at 2:49 PM
Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference - GlobeNewswireEvolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference - GlobeNewswire
www.globenewswire.com - February 13 at 8:33 AM
Evolus to Participate in 9th Annual SVB Leerink Global Healthcare ConferenceEvolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 13 at 8:33 AM
Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020 - GlobeNewswireEvolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020 - GlobeNewswire
www.globenewswire.com - February 12 at 8:53 AM
Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020
finance.yahoo.com - February 12 at 8:53 AM
UPDATE: Mizuho Securities Starts Evolus (EOLS) at Buy - StreetInsider.comUPDATE: Mizuho Securities Starts Evolus (EOLS) at Buy - StreetInsider.com
www.streetinsider.com - February 6 at 7:53 AM
3 Healthcare Stocks That Offer a Compelling Buying Opportunity - Nasdaq3 Healthcare Stocks That Offer a Compelling Buying Opportunity - Nasdaq
www.nasdaq.com - January 27 at 2:38 PM
Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crows Feet Lines Published in Dermatologic Surgery - GlobeNewswirePositive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow's Feet Lines Published in Dermatologic Surgery - GlobeNewswire
www.globenewswire.com - January 27 at 9:38 AM
Evolus (EOLS) Reports Positive Results from Phase 3, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA & PrabotulinumtoxinA - StreetInsider.comEvolus (EOLS) Reports Positive Results from Phase 3, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA & PrabotulinumtoxinA - StreetInsider.com
www.streetinsider.com - January 27 at 9:38 AM
Evolus Jeuveau matches Botox in study; shares up 3% premarket - Seeking AlphaEvolus' Jeuveau matches Botox in study; shares up 3% premarket - Seeking Alpha
seekingalpha.com - January 27 at 9:38 AM
Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow’s Feet Lines Published in Dermatologic SurgeryPositive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow’s Feet Lines Published in Dermatologic Surgery
finance.yahoo.com - January 27 at 9:38 AM
Evolus: A Wrinkle For Botox - Seeking AlphaEvolus: A Wrinkle For Botox - Seeking Alpha
seekingalpha.com - January 13 at 5:05 PM
ALPHAEON Corporation Completes Reorganization to Simplify its Corporate Structure - Business WireALPHAEON Corporation Completes Reorganization to Simplify its Corporate Structure - Business Wire
www.businesswire.com - January 11 at 1:33 AM
ALPHAEON Corporation Completes Reorganization to Simplify its Corporate Structure - Yahoo FinanceALPHAEON Corporation Completes Reorganization to Simplify its Corporate Structure - Yahoo Finance
finance.yahoo.com - January 10 at 8:32 PM
Health Care Sector Update for 01/09/2020: EOLS,DBVT,ARGX,CANF - NasdaqHealth Care Sector Update for 01/09/2020: EOLS,DBVT,ARGX,CANF - Nasdaq
www.nasdaq.com - January 9 at 4:28 PM
Evolus (EOLS) Reports Prelim. Q4 Results - StreetInsider.comEvolus (EOLS) Reports Prelim. Q4 Results - StreetInsider.com
www.streetinsider.com - January 9 at 4:28 PM
Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue - Yahoo FinanceEvolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue - Yahoo Finance
finance.yahoo.com - January 9 at 11:28 AM
Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 RevenueEvolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue
finance.yahoo.com - January 9 at 11:28 AM
Need To Know: Evolus, Inc. (NASDAQ:EOLS) Insiders Have Been Buying Shares - Yahoo FinanceNeed To Know: Evolus, Inc. (NASDAQ:EOLS) Insiders Have Been Buying Shares - Yahoo Finance
finance.yahoo.com - January 6 at 3:19 PM
Need To Know: Evolus, Inc. (NASDAQ:EOLS) Insiders Have Been Buying SharesNeed To Know: Evolus, Inc. (NASDAQ:EOLS) Insiders Have Been Buying Shares
finance.yahoo.com - January 6 at 3:19 PM
Evolus: Much Better Than Expected - Seeking AlphaEvolus: Much Better Than Expected - Seeking Alpha
seekingalpha.com - December 24 at 12:11 AM
Is Evolus, Inc. (EOLS) A Good Stock To Buy? - Yahoo FinanceIs Evolus, Inc. (EOLS) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - December 17 at 9:01 PM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel